首頁 > 市場調查報告書 > 製藥

疼痛動物用醫藥

市場調查報告書

商品編碼

2024734

獸醫疼痛管理市場報告：按產品類型、動物種類、應用、最終用戶和地區分類（2026-2034 年）

Veterinary Pain Management Market Report by Product, Animal Type, Application, End User, and Region 2026-2034

出版日期: 2026年04月01日 | 出版商:

IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

全球獸醫疼痛管理市場在2025年達到17億美元。 IMARC Group預測，到2034年，該市場將達到28億美元，2026年至2034年的複合年成長率為5.51%。推動該市場成長的因素包括寵物飼養家庭數量的增加、監管核准的增加以及包括關節炎、癌症、關節疼痛和術後疼痛在內的慢性疾病盛行率的上升。

獸醫疼痛管理市場的發展趨勢：

寵物飼主數量增加

寵物飼主數量的不斷成長推動了對獸醫服務（包括疼痛管理）的需求。寵物飼主將寵物視為家庭成員，並不斷增加在醫療服務上的支出，以確保寵物的健康。因此，對獸醫疼痛管理服務（例如鎮痛藥、物理療法和術後護理）的需求日益成長。隨著寵物飼主對寵物健康問題的關注度不斷提高，他們也更願意投資先進的獸醫服務，包括慢性疼痛和急性疼痛的預防和治療措施。這種消費者行為的轉變，加上個人收入水準的提高，是獸醫疼痛管理市場成長要素之一。根據 Dogster 預測，到 2026 年，印度的寵物貓數量預計將達到 489 萬隻。

獲得各監管機構的核准

2023年5月2日，禮來動物保健公司宣布，美國農業部（USDA）已對其首個犬細小病毒單株抗體產品給予有條件批准。這是首個也是目前唯一已通過核准的、經證實對犬細小病毒有效的治療藥物。犬小病毒是犬隻最具傳染性和致命性的治療方法之一（如不治療，死亡率高達91%）。此外，監管核准在獸醫疼痛管理市場中發揮著至關重要的作用，它確保藥品和治療方法安全、有效且適用於動物。美國食品藥物管理局（FDA）和歐洲藥品管理局（EMA）等主要監管機構負責監督獸醫疼痛管理產品的核准流程，並確保這些治療方法符合嚴格的安全性和有效性標準。

慢性病增多

關節炎、癌症和退化性關節疾病等慢性疾病發生率的不斷上升，為獸醫疼痛管理市場帶來了良好的前景。這些疾病會導致嚴重的疼痛和不適，在老年寵物中更為常見，尤其是犬貓。慢性疾病也會影響需要疼痛管理的牲畜和馬匹。此外，更先進的診斷工具的出現使得這些疾病能夠被更早發現，使獸醫能夠更有效地制定疼痛管理方案。同時，各公司正在研發治療方法，以減輕這些慢性疾病對動物帶來的痛苦。例如，2023年11月13日，Krka公司宣布推出Robexera，這是第一個羅貝考昔學名藥藥，旨在緩解接受軟組織手術的犬隻以及患有慢性骨關節炎（OA）的犬隻的疼痛和發炎。

The global veterinary pain management market size reached USD 1.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2034, exhibiting a growth rate (CAGR) of 5.51% during 2026-2034. There are several factors that are driving the market, which include the rising number of pet parents, various regulatory approvals, and increasing prevalence of chronic diseases such as arthritis, cancer, joint pain, and post-surgical pain.

Veterinary Pain Management Market Analysis:

Major Market Drivers: The market is experiencing moderate growth because of the increasing awareness about animal welfare and technological advancements.
Key Market Trends: The growing number of pet parents and various regulatory approvals are key market trends.
Geographical Trends: North America exhibits a clear dominance, accounting for the biggest market share owing to the presence of state-of-the-art hospitals and clinics equipped with modern diagnostic and treatment technologies.
Competitive Landscape: Top market players in the veterinary pain management industry are Alivira Animal Health Limited, Animalcare Group Plc, Boehringer Ingelheim Animal Health USA Inc, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals, Elanco, Merck & Co., Inc, Norbrook, Vetoquinol Group, and Zoetis Services LLC, among many others.
Challenges and Opportunities: Regulatory hurdles represent a key market challenge. Nonetheless, the expansion into emerging markets, along with the increasing focus on telemedicine, is anticipated to overcome these challenges and offer recent market opportunities.

Veterinary Pain Management Market Trends:

Rising Number of Pet Parents

The increasing number of pet parents is catalyzing the demand for veterinary care, including pain management. Pet parents view their pets as a part of their family, leading to higher spending on health services to ensure their pets' well-being. There is a rise in the need for veterinary pain management services, such as pain relief medications, physiotherapy, and post-surgical treatments. As pet parents are becoming more aware of their pets' health issues, they are willing to invest in advanced veterinary treatments including preventive and therapeutic measures for chronic and acute pain. This shift in consumer behavior, coupled with inflating income levels of individuals, is representing one of the major veterinary pain management market growth factors. According to Dogster, the pet cat population is anticipated to reach 4.89 million by 2026 in India.

Various Regulatory Approvals

On 2 May 2023, Elanco Animal Health Incorporated announced that the U.S. Department of Agriculture (USDA) provided a conditional license for the first Canine Parvovirus Monoclonal Antibody. This was the first and only approved therapeutic solution proven to treat canine parvovirus, one of the most contagious and deadly viruses a dog can contract with a 91% mortality rate if not treated with supportive care. In addition, regulatory approvals play a critical role in the veterinary pain management market by ensuring that drugs and therapies are safe, effective, and tailored for use in animals. Key regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are overseeing the approval process for veterinary pain management products while ensuring that these treatments meet stringent safety and efficacy standards.

Increasing Prevalence of Chronic Diseases

Rising incidences of chronic diseases such as arthritis, cancer, and degenerative joint diseases are offering a favorable veterinary pain management market outlook. These illnesses, which cause severe discomfort and pain, are more common in older pets, particularly in dogs and cats. Chronic illnesses also affect livestock and equine animals that require pain management. Furthermore, the availability of more advanced diagnostic tools enables early detection of these diseases and allowing veterinarians to prescribe pain management solutions more effectively. Additionally, businesses are creating treatments to help lessen the suffering that these chronic illnesses cause in animals. For example, on November 13, 2023, Krka announced the release of Robexera, the first generic version of robenacoxib intended to relieve pain and inflammation in dogs undergoing soft tissue surgery and chronic osteoarthritis (OA).

Veterinary Pain Management Market Segmentation:

Breakup by Product:

Drugs
- NSAIDs
- Anesthetics
- Opioids
- Other Drugs
Devices
- Laser Therapy
- Electromagnetic Therapy

Drugs account for the majority of the market share

Drugs are used to treat pain and inflammation in pets and are widely prescribed due to their effectiveness and relatively mild side effect profiles. Veterinarians and pet parents are recognizing the importance of effective pain management in improving the quality of life for animals. This awareness is leading to a high demand for pain relief medications. As more pets experience chronic conditions, the demand for effective pain management solutions continues to rise. This trend drives the consumption of pain-relief medications.

Breakup by Animal Type:

Companion
Livestock

Pets like dogs and cats as well as smaller animals like rabbits and guinea pigs are considered companion animals. Pet parents are more likely to look for ways to relieve their furry friends' pain. Chronic diseases including cancer, arthritis, and dental discomfort are common in aging pets, making appropriate pain management techniques necessary. The prevalence of these conditions drives the consumption of NSAIDs, opioids, and other pain management drugs.

Livestock animals comprise pigs, poultry, sheep, and cattle. Livestock is an important source of income for farmers and economies. To maintain livestock welfare and maximize production, it is imperative to provide appropriate pain treatment to ensure the health and productivity of these animals. Enough pain treatment for animals having surgery or suffering from illnesses is becoming more and more important. Equine patients frequently experience ailments like mastitis in dairy cows, lameness in sheep, and pain following surgery, necessitating the implementation of efficient pain treatment techniques.

Breakup by Application:

Osteoarthritis and Joint Pain
Postoperative Pain
Cancer
Others

Osteoarthritis and joint pain represent the leading market segment

The rising prevalence of osteoarthritis and joint pain among animals is bolstering the market growth. As pets age, they become more susceptible to osteoarthritis and other joint-related issues. This is particularly frequent in larger dog breeds, which tend to develop joint problems earlier in life. In addition, the high prevalence of obesity in pets is a factor in joint stress and osteoarthritis development. Overweight pets are more likely to experience joint pain, which is leading to a positive veterinary pain management market forecast.

Breakup by End User:

Hospitals and Clinics
Others

Hospitals and clinics exhibit a clear dominance in the market

The main healthcare providers for pets and animals are veterinary hospitals and clinics as they provide a variety of services like diagnosis, treatment, and pain management. They can address a variety of health conditions including pain management efficiently. These clinics also employ support personnel who have received specific training in pain treatment, as well as licensed veterinarians. This knowledge guarantees that animals receive proper evaluations, diagnoses, and treatments catered to their individual requirements. Many pet parents regularly bring their pets to clinics and hospitals for check-ups, vaccinations, and other preventive care.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest veterinary pain management market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for veterinary pain management.

North America, especially the United States and Canada, has one of the highest rates of pet parents. As per Forbes, as of 2024, around 66% of households in the United States own a pet. Moreover, cutting-edge veterinary hospitals and clinics with advanced diagnostic and therapeutic equipment are present throughout the North American region. These facilities allow veterinarians to recognize and treat animal pain accurately. Furthermore, there is a strong cultural emphasis on animal welfare in North America, leading to greater awareness among pet parents and veterinarians about the importance of pain management. All these factors are providing veterinary pain management market overview in the region.

Competitive Landscape:

Leading companies are allocating resources for research and development (R&D) activities aimed at creating novel and sophisticated pain management commodities such as dietary supplements, painkillers, and therapeutic interventions. For better animal care, they are introducing targeted medicines such monoclonal antibodies. As to confirm the effectiveness and safety of their products, some businesses are carrying out clinical trials, which aid in receiving regulatory clearances and increasing consumer acceptance. Moreover, companies are concentrating on joint ventures and acquisitions to broaden their range of products across diverse regions. For example, on 2 May 2023, Virbac acquired its distributor in the Czech Republic and Slovakia. This new Virbac subsidiary will enable the company to respond more widely and quickly to the health needs of animals in the Czech Republic and Slovakia.

The report provides a comprehensive analysis of the competitive landscape in the global veterinary pain management market with detailed profiles of all major companies, including:

Alivira Animal Health Limited
Animalcare Group Plc
Boehringer Ingelheim Animal Health USA Inc
Ceva Sante Animale
Chanelle Pharma
Dechra Pharmaceuticals
Elanco
Merck & Co., Inc
Norbrook
Vetoquinol Group
Zoetis Services LLC

Frequently Asked Questions About the Veterinary Pain Management Market Report

1.How big is the global veterinary pain management market?

2.What is the expected growth rate of the global veterinary pain management market during 2026-2034?

3.What are the key factors driving the global veterinary pain management market?

4.What has been the impact of COVID-19 on the global veterinary pain management market?

5.What is the breakup of the global veterinary pain management market based on the product?

6.What is the breakup of the global veterinary pain management market based on the application?

7.What is the breakup of the global veterinary pain management market based on the end user?

8.What are the key regions in the global veterinary pain management market?

9.Who are the key players/companies in the global veterinary pain management market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Veterinary Pain Management Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Drugs
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 NSAIDs
  - 6.1.2.2 Anesthetics
  - 6.1.2.3 Opioids
  - 6.1.2.4 Other Drugs
- 6.1.3 Market Forecast
6.2 Devices
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Laser Therapy
  - 6.2.2.2 Electromagnetic Therapy
- 6.2.3 Market Forecast

7 Market Breakup by Animal Type

7.1 Companion
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Livestock
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Application

8.1 Osteoarthritis and Joint Pain
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Postoperative Pain
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Cancer
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Others
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Alivira Animal Health Limited
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Animalcare Group Plc
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Boehringer Ingelheim Animal Health USA Inc
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Ceva Sante Animale
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 Chanelle Pharma
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Dechra Pharmaceuticals
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
- 15.3.7 Elanco
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Merck & Co., Inc
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Norbrook
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
- 15.3.10 Vetoquinol Group
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
- 15.3.11 Zoetis Services LLC
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Veterinary Pain Management Market: Major Drivers and Challenges
Figure 2: Global: Veterinary Pain Management Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Veterinary Pain Management Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Veterinary Pain Management Market: Breakup by Product (in %), 2025
Figure 5: Global: Veterinary Pain Management Market: Breakup by Animal Type (in %), 2025
Figure 6: Global: Veterinary Pain Management Market: Breakup by Application (in %), 2025
Figure 7: Global: Veterinary Pain Management Market: Breakup by End User (in %), 2025
Figure 8: Global: Veterinary Pain Management Market: Breakup by Region (in %), 2025
Figure 9: Global: Veterinary Pain Management (Drugs) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: Veterinary Pain Management (Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: Veterinary Pain Management (Devices) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Veterinary Pain Management (Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Veterinary Pain Management (Companion) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Veterinary Pain Management (Companion) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Veterinary Pain Management (Livestock) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Veterinary Pain Management (Livestock) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Veterinary Pain Management (Osteoarthritis and Joint Pain) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Veterinary Pain Management (Osteoarthritis and Joint Pain) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Veterinary Pain Management (Postoperative Pain) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Veterinary Pain Management (Postoperative Pain) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Veterinary Pain Management (Cancer) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Veterinary Pain Management (Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: Veterinary Pain Management (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: Veterinary Pain Management (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: Veterinary Pain Management (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: Veterinary Pain Management (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Global: Veterinary Pain Management (Others) Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Global: Veterinary Pain Management (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: North America: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: North America: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: United States: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: United States: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Canada: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Canada: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Asia-Pacific: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Asia-Pacific: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: China: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: China: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Japan: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Japan: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: India: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: India: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: South Korea: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: South Korea: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Australia: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Australia: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Indonesia: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Indonesia: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Others: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Others: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Europe: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Europe: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: Germany: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: Germany: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: France: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: France: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: United Kingdom: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: United Kingdom: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Italy: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Italy: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Spain: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Spain: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Russia: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Russia: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: Others: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: Others: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: Latin America: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: Latin America: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: Brazil: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: Brazil: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Mexico: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Mexico: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Others: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Others: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 75: Middle East and Africa: Veterinary Pain Management Market: Sales Value (in Million USD), 2020 & 2025
Figure 76: Middle East and Africa: Veterinary Pain Management Market: Breakup by Country (in %), 2025
Figure 77: Middle East and Africa: Veterinary Pain Management Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 78: Global: Veterinary Pain Management Industry: SWOT Analysis
Figure 79: Global: Veterinary Pain Management Industry: Value Chain Analysis
Figure 80: Global: Veterinary Pain Management Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Veterinary Pain Management Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Veterinary Pain Management Market Forecast: Breakup by Product (in Million USD), 2026-2034
Table 3: Global: Veterinary Pain Management Market Forecast: Breakup by Animal Type (in Million USD), 2026-2034
Table 4: Global: Veterinary Pain Management Market Forecast: Breakup by Application (in Million USD), 2026-2034
Table 5: Global: Veterinary Pain Management Market Forecast: Breakup by End User (in Million USD), 2026-2034
Table 6: Global: Veterinary Pain Management Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 7: Global: Veterinary Pain Management Market: Competitive Structure
Table 8: Global: Veterinary Pain Management Market: Key Players

02-2729-4219

+886-2-2729-4219